Company Description

SignaBlok is a biopharmaceutical company developing novel targeted therapeutics and delivery nanosystems through the use of their revolutionary science and technologies, they offer high quality innovation, science and management expertise, encouraging results, an impressive IP portfolio, and growing involvement in international research.